"Dyskinesia impacts quality of life of people with
Post# of 30028
Posted On: 03/10/2015 9:39:21 AM
"Dyskinesia impacts quality of life of people with Parkinson's disease, and is therefore a top priority for the Foundation," commented Maurizio Facheris, M.D., M.Sc., Associate Director of research programs at The Michael J. Fox Foundation. "We are glad to see this project moving further through clinical testing and closer to patients' hands."
http://ir.amarantus.com/company-news/detail/1...dyskinesia
The Research Programs team, made up of PhD and MD neuroscientists paired with business-trained project managers, manages the Foundation’s research portfolio of approximately 250 active grants. This team works closely with Foundation peer reviewers to make funding decisions, direct research goals and troubleshoot issues as they arise.
Maurizio Facheris, MD, MSc
Senior Associate Director
Research Programs
https://www.michaeljfox.org/foundation/leader...h-programs
Cheers
http://ir.amarantus.com/company-news/detail/1...dyskinesia
The Research Programs team, made up of PhD and MD neuroscientists paired with business-trained project managers, manages the Foundation’s research portfolio of approximately 250 active grants. This team works closely with Foundation peer reviewers to make funding decisions, direct research goals and troubleshoot issues as they arise.
Maurizio Facheris, MD, MSc
Senior Associate Director
Research Programs
https://www.michaeljfox.org/foundation/leader...h-programs
Cheers
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼